ホーム › 膵臓がん › ペンシルベニア › Philadelphia
Philadelphia、PAにおける膵臓がんの臨床試験
Philadelphiaとその周辺地域（約30マイル以内）の拠点で、膵臓がんに関する26件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
被験者募集中第3相
- Thomas Jefferson University, Philadelphia
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
被験者募集中第1相
- Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University, Philadelphia
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
被験者募集中第3相
- University of Pennsylvania, Abramson Cancer Center, Philadelphia
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
被験者募集中第3相
- Investigative Site US008, Philadelphia
- Investigative Site US043, Philadelphia
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
被験者募集中第1/2相
- Hospital of the University of Pennsylvania, Philadelphia
Prehabilitation in High-risk Oncologic Surgery
被験者募集中
- Fox Chase Cancer Center - Philadelphia, Philadelphia
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
被験者募集中第2相
- Thomas Jefferson University, Sidney Kimmel Comprensive Cancer Center, Clinical Trials Office, Philadelphia
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
被験者募集中観察研究
- Children's Hospital of Philadelphia, Philadelphia
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
被験者募集中観察研究
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- 他5件
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
被験者募集中第3相
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23マイル先
- 他1件
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
被験者募集中第1相
- Investigative Site #109, Philadelphia
Pancreatic Cancer Early Detection Consortium
被験者募集中観察研究健康なボランティア歓迎
- University of Pennsylvania, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
被験者募集中第1相
- Sidney Kimmel Cancer Center, Philadelphia
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
被験者募集中第3相
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23マイル先
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25マイル先
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
被験者募集中第1/2相
- Univ of Pennsylvania, Abramson Cancer Center, Philadelphia
Collection of Circulating Biomarkers in Pancreatic Cancer
被験者募集中観察研究
- Abramson Cancer Center at University of Pennsylvania, Philadelphia
Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
被験者募集中第2相
- Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital, Philadelphia
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
被験者募集中第1/2相
- University of Pennsylvania, Philadelphia
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- University of Pennsylvania, Philadelphia
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
被験者募集中第2相
- Ohio State University-Telemedicine, Philadelphia
- Ohio State University-Telemedicine, Wilmington · 25マイル先
Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk
被験者募集中観察研究
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
FTT PET/CT in Pancreatic Neuroendocrine Tumors
被験者募集中第1相
- University of Pennsylvania, Perelman Center for Advanced Medicine, Philadelphia
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
被験者募集中観察研究
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25マイル先
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Philadelphia
The Cancer of the Pancreas Screening-5 CAPS5)Study
被験者募集中第3相
- University of Pennsylvania, Philadelphia
他の都市における膵臓がんの試験
- Houston, TX61件の研究
- New York City, NY60件の研究
- Boston, MA43件の研究
- Nashville, TN39件の研究
- Los Angeles, CA35件の研究
- St. Louis, MO33件の研究
- Arlington, VA33件の研究
- Baltimore, MD31件の研究
- San Antonio, TX31件の研究
- Tampa, FL26件の研究
- Durham, NC24件の研究
- San Diego, CA24件の研究
Philadelphiaにおける他の研究
- がん（全種類）59件の研究
- 乳がん56件の研究
- 非小細胞肺癌51件の研究
- 転移性癌46件の研究
- 前立腺がん44件の研究
- 大腸癌44件の研究
- 卵巣がん44件の研究
- 肺がん36件の研究
- 急性骨髄性白血病34件の研究
- 心不全31件の研究
- 子宮内膜がん28件の研究
- うつ病26件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。